Detalhe da pesquisa
1.
Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients.
J Neurooncol
; 147(1): 109-116, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974803
2.
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study.
Oncol Res Treat
; 38(7-8): 348-54, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26278578
3.
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.
Oncol Rep
; 23(6): 1655-62, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20428822